ATG5 and acute myeloid leukemia: Mice transplanted with a single pool of Atg5WT cells and treated with vehicle or tamoxifen succumbed to AML without a significant difference in median survival, suggesting that active Cre recombinase or tamoxifen does not affect the survival of leukemic mice in the absence of Atg5 deletion (Figure 3a).